Essex Woodlands Healthcare Partners β Full Portfolio
32 tracked investments Β· listed companies and verified rows first
Axogen develops and commercializes technologies for peripheral nerve regeneration and repair, offering clinically proven surgical solutions to restore feeling and function to damaged nerves.
BiotechHealthtechMedical Devices
Michael Dale(Director, Chief Executive Officer and President)in
MediciNova is a biopharmaceutical company developing therapeutics for neurology, respiratory, and liver diseases with unmet medical needs.
Biotech
Yuichi Iwaki(President, Chief Executive Officer and Executive Chairman of our Board)Kazuko Matsuda(Senior Vice President, Chief Medical Officer)David H. Crean(Chief Business Officer)Jason Kruger(Chief Financial Officer)
Co-investorsDIMENSIONNippon Venture CapitalUTEC
MIMEDX develops advanced wound care and surgical products derived from placental tissue, serving healthcare professionals and patients.
BiotechHealthtechMedical DevicesMarietta, US
William C. Taylor(Executive Officer, Director)Parker H. Petit(Executive Officer, Director)Alexandra O. Haden(Executive Officer)Michael J. Senken(Executive Officer)Joseph H. Capper(Chief Executive Officer)Doug Rice(Chief Financial Officer)in
Sonendo is a medical technology company that develops and manufactures the GentleWave System, a technology platform for treating tooth decay by cleaning and disinfecting the interior spaces of teeth without removing tooth structure.
HardwareHealthtechMedical DevicesLaguna Hills, US
Bjarne Bergheim(Executive Officer, Director)inJohn McGaugh(Executive Officer)inJohn Bostjancic(Executive Officer)Hugh Neuharth(Executive Officer)Roy T. Chen(Chief Talent Officer)Chris Guo(Interim Chief Financial Officer)in
PartnerBrooks AndrewsΒ· led
Co-investorsFjord VenturesGeneral AtlanticMeritech Capital PartnersOrbiMedPura Vida InvestmentsWelsh, Carson, Anderson & Stowe
Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.
BiotechMalvern, US
Antony Koblish(Founder)inFrancis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)
BoardKevin Rakin(Director)inAshley Freidman(Director)
Co-investorsCheckmate Capital Group LLCHighCape CapitalOrbiMedSignet Healthcare Partners1315 CapitalRTW Investments L.P.
Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.
BiotechHardwareHealthtechMedical DevicesDublin 2, US
Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)inPaul Bae(Chief Administrative Officer and General Counsel)inDavid Prutchi(Executive Vice President, Chief Technology Officer)inRichard J. Buchholz(Chief Financial Officer)Anthony Hong(Chief Science and Strategy Officer)in
Board seatGuido NeelsΒ· per SEC Form D Β· $140M raise Β· filed Mar 2025
Co-investorsAmzak HealthAlgerBraidwellREDMILESands Capital VenturesSignet Healthcare Partners
BioTissue develops regenerative medicine products derived from human birth tissue to treat wounds and chronic pain.
BiotechHealthtechMedical DevicesMiami, US
Scheffer C.G. Tseng(Chief Scientific Officer)
Co-investorsBallast Point Ventures
Bioventus develops and markets medical devices for active healing, including pain management, restorative therapies, and surgical solutions that aim to enhance the body's natural healing processes and reduce the need for invasive procedures.
BiotechDeep TechHealthtechMedical DevicesDurham, US
Robert Claypoole(Chief Executive Officer)
Co-investorsAlta PartnersAmpersand
This page is an affiliate partner listing for Breg, not a company profile page.
Digital HealthHardwareHealthtechMedical DevicesCarlsbad, US
Dave Mowry(Executive Chairman and Chief Executive Officer)inSteve Ingel(President)in
Cardiva Medical, part of Haemonetics, develops the VASCADE family of vascular closure systems, including venous and arterial closure devices used in cardiovascular procedures.
HardwareHealthtechMedical DevicesSanta Clara, US
George Lee(Director)Lisa Garrett(Executive Officer)Michael Bornitz(Director)Rick Anderson(Director)John Russell(Executive Officer, Director)Augustine Lien(Director)
Co-investorsEvidity Health CapitalLuther King Capital ManagementPTV Healthcare Capital
Germfree provides cleanroom and biocontainment facility solutions for pharmaceutical, pharmacy, and biopharma manufacturing, leveraging over 60 years of experience and in-house fabrication technology.
Advanced ManufacturingBiotechCleantechHardwareHealthtechMedical DevicesOrlando, US
Carol Houts(Chief Executive Officer)in
Majorelle is a French pharmaceutical laboratory that develops treatments, medical devices, and health products across three therapeutic areas: women's health, urology, and family health.
BiotechFemTechHealthtech
PartnerEvis HurseverΒ· led
Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data.
AI & Machine LearningBiotechHealthtechDurham, US
John A. Ryals(Executive Officer, Director)inGerald M. Haines II(Executive Officer)Rohan F. Hastie(Executive Officer, Director)in
BoardJohn Oxaal(Director)R. Scott Barry(Director)R. John Fletcher(Director)
Co-investorsCamden PartnersHavencrest Capital ManagementRevelation PartnersSyngenta Group Ventures
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units.
BiotechHealthtechMedical DevicesCity Of Industry, US
Scott Elster(Executive Officer, Director)inJohn M. Shields(Executive Officer)in
BoardFrank Foster(Director)Martin Sutter(Director)David Brailer(Director)Dan Janney(Director)
Co-investorsAisling CapitalFrontier Venture CapitalPROOFAlta Partners
A company offering regenerative and aesthetic medical products for facial, breast, and body treatments across all stages of life.
HealthtechMedical DevicesSan Diego, US
Nicholas L. Teti, Jr.(Executive Officer, Director)Joseph A. Newcomb(Executive Officer)Stewart M. Brown(Executive Officer)in
BoardClarke B. Futch(Director)Paul J. Hadden(Director)Todd C. Davis(Director)
Co-investorsBioBritPolaris Partners
Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies.
BiotechHardwareHealthtechMedical DevicesToronto, US
Domenic Serafino(Executive Officer, Director)inKirk Gunhus(Executive Officer)inRoss Portaro(Executive Officer)inAnna Georgiadis(Executive Officer)inMelissa Kang(Executive Officer)inMichael Mandarello(Executive Officer)in
Co-investorsAPERTURE Venture PartnersLongitude CapitalClarusHealthQuest Capital
HealthtechCampbell, US
Nersi Nazari(Executive Officer, Director)inSteve Zadig(Executive Officer, Director)
BoardRichard Feachem(Director)Tom Saunders(Director)
Co-investorsAsahi Kasei Corporate Venture CapitalRevelation PartnersAlly Bridge GroupMVM Life Science PartnersTrinity Capital
Xenex builds pulsed Xenon UV light disinfection robots that deactivate pathogens missed during manual cleaning, used by hospitals to reduce environmental contamination and healthcare-associated infections.
HealthtechMedical DevicesRoboticsSan Antonio, US
Mark (Tuck) Stibich(Co-founder)Julie Stachowiak(Co-founder)Morris Miller(Co-founder & CEO)in
Co-investorsBattery VenturesTargeted Technology FundsTectonic Ventures
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Endologix INC /DeAcura Pharmaceuticals, Inc.AscendBoironCognate BioservicesCotaEncore DermatologyEnercon TechnologiesEUSA PharmaEyePoint Pharmaceuticals, Inc.Grundium OyKona MedicalSerene, LLCXenex Disinfection Services, Inc.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.